This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

George Rosenkranz To Receive 2013 Biotechnology Heritage Award

Award presented during keynote lunch at the 2013 BIO International Convention.

CHICAGO and PHILADELPHIA, April 21, 2013 /PRNewswire-USNewswire/ -- The Chemical Heritage Foundation (CHF) and the Biotechnology Industry Organization (BIO) have selected George Rosenkranz as the winner of the 2013 Biotechnology Heritage Award. The award will be presented during a keynote lunch on Tuesday, April 23, at BIO's  annual international convention, which begins tomorrow in Chicago.

" George Rosenkranz has pioneered with brilliance in steroid chemistry; innovated with legendary success in the pharmaceutical industry; and recruited, mentored, and guided individuals of great talent to stellar careers. He unites in his person European charm, Hispanic courtesy, and American entrepreneurial spirit," says James C. Greenwood, President and CEO of BIO. "George led the development of the oral contraceptive pill, served as chairman of the corporation that brought it to the global market, and thereby permanently changed world culture."

About George Rosenkranz



George Rosenkranz joined Syntex Corporation in 1945 and retired as CEO and board chairman in 1981. During his years with Syntex, Rosenkranz created and guided an academic research group of star-studded brilliance, which included Alex Zaffaroni and Carl Djerassi, first as his junior collaborators, then as his lifelong friends. Revolutionary advances in the intellectual understanding of and production techniques for steroid drugs were developed under Rosenkranz's direction, using native Mexican plant sources as raw materials. Syntex became the leading supplier of the oral contraceptive pill and other corticoids.

Rosenkranz's accomplishments have encompassed every aspect of the steroid hormone industry. He holds over 150 patents and has published more than 300 research articles on steroid hormones.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs